Anemia Due to Acute Blood Loss¶
Chapter 106 | Acute Hemorrhagic Anemia
KEY CLINICAL POINTS¶
- Acute blood loss causes anemia via direct red cell loss or gradual iron depletion (covered in Chap. 102).
- Clinical stages: hypovolemia → hemodilution → marrow compensation; hypotension and organ hypoperfusion dominate early.
- Immediate management prioritizes hemostasis, volume resuscitation (plasma preferred over saline), and transfusion for hemoglobin <70–80 g/L.
- Differential diagnosis includes hemolysis, iron deficiency, and chronic anemia with delayed symptoms.
- Special considerations: trauma, obstetric hemorrhage, and post-surgical bleeding require rapid intervention.
1. DEFINITION & OVERVIEW¶
Acute blood loss anemia results from sudden red cell loss, primarily from external (trauma, obstetrics) or internal (GI bleeding, ruptured spleen) hemorrhage. Two mechanisms: (1) direct red cell loss; (2) prolonged bleeding depletes iron stores (iron deficiency anemia, discussed in Chap. 102).
Stages of Acute Blood Loss¶
| Stage | Clinical Features | Hemoglobin Threshold |
|---|---|---|
| Hypovolemia | Tachycardia, hypotension, oliguria | Normal/› |
| Hemodilution | Tachypnea, cold extremities | fl to 7–8 g/dL |
| Marrow Compensation | Reticulocytosis, erythropoietin › | Stable/› |
1.1 Pathophysiology¶
Three clinical stages: (1) Hypovolemia: critical organ hypoperfusion (brain, kidneys); (2) Hemodilution: plasma expands, hemoglobin falls; (3) Marrow compensation: reticulocytosis and erythropoietin elevation. Acute losses >40% cause hypovolemic shock.
2. EPIDEMIOLOGY¶
Acute blood loss is common in trauma, obstetrics, and GI bleeding. Risk factors: trauma, coagulopathy, anticoagulant use, and vascular abnormalities. Prevalence varies by population; mortality correlates with blood loss volume and delayed resuscitation.
2.1 Demographics¶
Common in trauma patients, postpartum women, and individuals with GI bleeding (e.g., peptic ulcer, diverticulosis). Elderly and pediatric populations have distinct clinical presentations.
3. ETIOLOGY & PATHOPHYSIOLOGY¶
Direct red cell loss from external or internal hemorrhage. Prolonged bleeding may deplete iron stores (iron deficiency anemia). Pathophysiology involves hypovolemia, hemodilution, and compensatory marrow hyperplasia. Acute losses >30% trigger sympathetic activation; >40% cause shock.
3.1 Mechanisms¶
Hypovolemia → reduced organ perfusion → sympathetic activation → hemodilution → marrow compensation. Acute losses >40% (2 L in adults) cause hypovolemic shock with confusion, tachycardia, and hypotension.
4. CLINICAL FEATURES¶
Symptoms: tachycardia, hypotension, dyspnea, diaphoresis. Signs: cold pale skin, decreased pulse pressure, oliguria. Severe anemia (hemoglobin <70–80 g/L) presents with confusion and shock. Chronic anemia may have fatigue, breathlessness, and tachycardia with exertion.
4.1 Complications¶
Acute renal failure, hypoxia, and organ failure from hypoperfusion. Chronic anemia may cause increased 2,3-BPG and right-shifted O2 dissociation curve.
5. DIFFERENTIAL DIAGNOSIS¶
Hemolysis (e.g., PNH, G6PD deficiency), iron deficiency anemia, chronic disease anemia, and hemoglobinopathies. Acute blood loss must be distinguished from hemolytic anemia or delayed iron deficiency.
6. INVESTIGATIONS & DIAGNOSIS¶
CBC, reticulocyte count, lactate, and blood gas analysis. Imaging (ultrasound, endoscopy) for internal bleeding. Hemoglobin levels <70–80 g/L confirm severe anemia. Volume loss estimation: hemoglobin decline reflects blood loss (e.g., 7 g/dL ≈ 50% loss).
6.1 Diagnostic Criteria¶
Sudden hemoglobin drop, hypovolemic signs, and evidence of bleeding (e.g., Grey Turner/Cullen signs, hematemesis). Exclude hemolysis with lactate dehydrogenase and indirect bilirubin.
7. MANAGEMENT & TREATMENT¶
Immediate priorities: hemostasis, volume resuscitation (plasma preferred), and transfusion for hemoglobin <70–80 g/L. Long-term: address bleeding source and monitor for complications.
Management Approach¶
| Priority | Action | Rationale |
|---|---|---|
| 1 | Hemostasis | Stop active bleeding source |
| Priority | Action | Rationale |
|---|---|---|
| 2 | Volume Resuscitation | Plasma preferred over saline to avoid dilution of clotting factors |
| 3 | Transfusion | Hemoglobin <70–80 g/L indicates need for RBC transfusion |
| 4 | Monitoring | Track hemoglobin, urine output, and organ perfusion |
7.1 Algorithm¶
- Stabilize airway, breathing, circulation. 2. Administer vasopressors for hypotension. 3. Replace blood volume with plasma (not saline) to preserve clotting factors. 4. Transfuse RBCs for hemoglobin <70–80 g/L. 5. Identify and treat bleeding source (e.g., endoscopy, surgery).
8. PROGNOSIS & COMPLICATIONS¶
Prognosis depends on blood loss volume and timely intervention. Complications include hypovolemic shock, acute renal failure, and organ hypoperfusion. Chronic anemia may develop if bleeding is recurrent or prolonged.
8.1 Complications¶
Hypovolemic shock (hemoglobin <40 g/L), acute tubular necrosis, and metabolic acidosis. Delayed complications include iron deficiency and secondary erythrocytosis.
9. SPECIAL CONSIDERATIONS¶
Pregnancy: increased blood volume and risk of postpartum hemorrhage. Pediatrics: higher risk of hypovolemic shock. Elderly: comorbidities and reduced compensatory reserve. Post-surgical bleeding requires immediate transfusion and surgical intervention.
9.1 Obstetric Hemorrhage¶
Uterine atony, placental abruption, or lacerations. Rapid transfusion and uterine massage are critical. Coagulopathy may require fresh frozen plasma or platelets.
10. KEY POINTS & CLINICAL PEARLS¶
- Acute blood loss anemia is a medical emergency requiring immediate resuscitation. 2. Plasma is preferred over saline for volume expansion to preserve coagulation. 3. Hemoglobin <70–80 g/L necessitates transfusion. 4. Identify and control the bleeding source promptly. 5. Monitor for hypovolemic shock and organ dysfunction.